共 50 条
- [28] Visualizing CTL activity for different CD8+ effector T cells supports the idea that lower TCR/epitope avidity may be advantageous for target cell killing Cell Death & Differentiation, 2009, 16 : 537 - 542
- [30] TNFR2/CCR8 bispecific antibody enhances antitumor activity through depleting Ti-Tregs and boosting effector CD8+ T cell function ONCOIMMUNOLOGY, 2025, 14 (01):